What's New

FTD in the News

Title: ASPIRE-FTD Phase 1/2 Clinical Opens First US Site at Ohio State University - Ohio State University campus in background.

ASPIRE-FTD Phase 1/2 Clinical Trial Opens First US Site at Ohio State University

Biopharmaceutical company AviadoBio announced on July 1 that its ASPIRE-FTD phase 1/2 clinical trial has opened its…

Read More >
Graphic; Care Partner Emphasizes the Benefits of Support from Others Who Understand FTD

Care Partner Emphasizes the Benefits of Support from Others Who Understand FTD

Navigating the FTD journey is much less daunting when you have support from others who have lived…

Read More >
Title: opinion column highlights racial disparities in dementia care and need for support. Image: doctor viewing MRI imaging on tablet.

Opinion Column Highlights Racial Disparities in Dementia Care and Need for Support

An opinion column published in the Los Angeles Daily News highlights healthcare-based racial disparities that often leave…

Read More >

A Conversation with Olga Uspenskaya, MD, PhD, of Prevail Therapeutics

Recently, Prevail Therapeutics presented interim results from their Phase 1/2 open-label clinical trial assessing the safety and…

Read More >
Graphic title: Passage Bio Receives Positive Feedback from FDA on Expanding Gene Therapy to C9orf72. Image: Person working in lab, looking through microscope

Passage Bio Receives Positive Feedback from FDA on Expanding Gene Therapy to C9orf72

Biopharmaceutical company Passage Bio announced on July 16 that it has received positive feedback from the U.S….

Read More >
Graphic: Research Explains the Role of Genetics in FTD, Discusses Avenues for Treatment.

Researcher Explains the Role of Genetics in FTD, Discusses Avenues for Treatment

In an article written for The Conversation, Fen-Biao Gao, PhD, professor and founding director of the FTD…

Read More >
Graphic: British/Dutch Study Discovers Role of ANG Gene Mutations in ALS-FTD

British/Dutch Study Discovers Role of ANG Gene Mutations in ALS-FTD

Researchers at the University of Bath in the United Kingdom and the University Medical Center Utrecht in…

Read More >
Vesper Bio Completes Ascending Dose Phase

Vesper Bio Completes Single Ascending Dose Stage of Its Clinical Trial for Potential Disease Modifying Treatment for FTD-GRN

Biotechnology company Vesper Bio announces it has completed the single ascending dose stage in its clinical trial…

Read More >

Delaware Passes Resolution Recognizing FTD Awareness Week 2024

Delaware became the third state to officially recognize FTD Awareness Week 2024 (September 22-29) after its Senate…

Read More >
Graphic: Study Explores Racial Differences in Clinical Presentation of FTD Symptoms, Disease Severity

Study Explores Racial Differences in Clinical Presentation of FTD Symptoms, Disease Severity

A study published in JAMA Neurology explores whether FTD symptoms present differently based on the race of…

Read More >